ID   UHMK1_HUMAN             Reviewed;         419 AA.
AC   Q8TAS1; A0A0A6YYC2; A8K8K4; G3V1M1; Q96C22;
DT   19-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2002, sequence version 2.
DT   12-OCT-2022, entry version 188.
DE   RecName: Full=Serine/threonine-protein kinase Kist;
DE            EC=2.7.11.1;
DE   AltName: Full=Kinase interacting with stathmin;
DE   AltName: Full=PAM COOH-terminal interactor protein 2;
DE            Short=P-CIP2;
DE   AltName: Full=U2AF homology motif kinase 1;
GN   Name=UHMK1; Synonyms=KIS, KIST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAH26046.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1).
RX   PubMed=12782393; DOI=10.1016/s0169-328x(03)00132-3;
RA   Bieche I., Manceau V., Curmi P.A., Laurendeau I., Lachkar S., Leroy K.,
RA   Vidaud D., Sobel A., Maucuer A.;
RT   "Quantitative RT-PCR reveals a ubiquitous but preferentially neural
RT   expression of the KIS gene in rat and human.";
RL   Brain Res. Mol. Brain Res. 114:55-64(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH PAM.
RX   PubMed=10574929; DOI=10.1074/jbc.274.49.34646;
RA   Caldwell B.D., Darlington D.N., Penzes P., Johnson R.C., Eipper B.A.,
RA   Mains R.E.;
RT   "The novel kinase peptidylglycine alpha-amidating monooxygenase cytosolic
RT   interactor protein 2 interacts with the cytosolic routing determinants of
RT   the peptide processing enzyme peptidylglycine alpha-amidating
RT   monooxygenase.";
RL   J. Biol. Chem. 274:34646-34656(1999).
RN   [7]
RP   INTERACTION WITH CDKN1B, TISSUE SPECIFICITY, AND MUTAGENESIS OF LYS-54.
RX   PubMed=12093740; DOI=10.1093/emboj/cdf343;
RA   Boehm M., Yoshimoto T., Crook M.F., Nallamshetty S., True A., Nabel G.J.,
RA   Nabel E.G.;
RT   "A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and
RT   regulates cell cycle progression.";
RL   EMBO J. 21:3390-3401(2002).
RN   [8]
RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=23419774; DOI=10.1016/j.bbamcr.2013.02.004;
RA   Archangelo L.F., Greif P.A., Maucuer A., Manceau V., Koneru N.,
RA   Bigarella C.L., Niemann F., Dos Santos M.T., Kobarg J., Bohlander S.K.,
RA   Saad S.T.;
RT   "The CATS (FAM64A) protein is a substrate of the kinase interacting
RT   stathmin (KIS).";
RL   Biochim. Biophys. Acta 1833:1269-1279(2013).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-159 AND ASP-197.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Upon serum stimulation, phosphorylates CDKN1B/p27Kip1, thus
CC       controlling CDKN1B subcellular location and cell cycle progression in
CC       G1 phase. May be involved in trafficking and/or processing of RNA (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000305};
CC   -!- SUBUNIT: Interacts with stathmin and CDKN1B/p27Kip1 (By similarity).
CC       Interacts with PAM. {ECO:0000250, ECO:0000269|PubMed:10574929,
CC       ECO:0000269|PubMed:12093740}.
CC   -!- INTERACTION:
CC       Q8TAS1; Q15637: SF1; NbExp=4; IntAct=EBI-1753608, EBI-744603;
CC       Q8TAS1-2; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-12157345, EBI-8643161;
CC       Q8TAS1-2; P25800: LMO1; NbExp=3; IntAct=EBI-12157345, EBI-8639312;
CC       Q8TAS1-2; Q9BU61: NDUFAF3; NbExp=3; IntAct=EBI-12157345, EBI-2114801;
CC       Q8TAS1-2; P57771-2: RGS8; NbExp=3; IntAct=EBI-12157345, EBI-12058229;
CC       Q8TAS1-2; P62328: TMSB4X; NbExp=3; IntAct=EBI-12157345, EBI-712598;
CC       Q8TAS1-2; Q3SY00: TSGA10IP; NbExp=3; IntAct=EBI-12157345, EBI-10241197;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23419774}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TAS1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TAS1-2; Sequence=VSP_004908, VSP_004909;
CC       Name=3;
CC         IsoId=Q8TAS1-3; Sequence=VSP_046145;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in skeletal
CC       muscle, kidney, placenta and peripheral blood leukocytes.
CC       {ECO:0000269|PubMed:12093740}.
CC   -!- DEVELOPMENTAL STAGE: Regulated in a cell-cycle dependent manner, with
CC       lowest levels during S phase and highest at G1 phase (at protein
CC       level). {ECO:0000269|PubMed:23419774}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ536197; CAD60192.1; -; mRNA.
DR   EMBL; AK058195; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK292369; BAF85058.1; -; mRNA.
DR   EMBL; AL359699; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW90706.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW90707.1; -; Genomic_DNA.
DR   EMBL; BC014917; AAH14917.1; -; mRNA.
DR   EMBL; BC026046; AAH26046.1; -; mRNA.
DR   CCDS; CCDS1239.1; -. [Q8TAS1-1]
DR   CCDS; CCDS53423.1; -. [Q8TAS1-3]
DR   CCDS; CCDS53424.1; -. [Q8TAS1-2]
DR   RefSeq; NP_001171692.1; NM_001184763.1. [Q8TAS1-3]
DR   RefSeq; NP_653225.2; NM_144624.2. [Q8TAS1-2]
DR   RefSeq; NP_787062.1; NM_175866.4. [Q8TAS1-1]
DR   AlphaFoldDB; Q8TAS1; -.
DR   SMR; Q8TAS1; -.
DR   BioGRID; 126088; 20.
DR   IntAct; Q8TAS1; 42.
DR   STRING; 9606.ENSP00000420270; -.
DR   iPTMnet; Q8TAS1; -.
DR   PhosphoSitePlus; Q8TAS1; -.
DR   BioMuta; UHMK1; -.
DR   DMDM; 24211880; -.
DR   EPD; Q8TAS1; -.
DR   jPOST; Q8TAS1; -.
DR   MassIVE; Q8TAS1; -.
DR   PaxDb; Q8TAS1; -.
DR   PeptideAtlas; Q8TAS1; -.
DR   PRIDE; Q8TAS1; -.
DR   ProteomicsDB; 32376; -.
DR   ProteomicsDB; 73913; -. [Q8TAS1-1]
DR   ProteomicsDB; 73914; -. [Q8TAS1-2]
DR   Antibodypedia; 34322; 340 antibodies from 28 providers.
DR   DNASU; 127933; -.
DR   Ensembl; ENST00000489294.2; ENSP00000420270.1; ENSG00000152332.16. [Q8TAS1-1]
DR   Ensembl; ENST00000538489.5; ENSP00000446416.1; ENSG00000152332.16. [Q8TAS1-2]
DR   Ensembl; ENST00000545294.5; ENSP00000441226.1; ENSG00000152332.16. [Q8TAS1-3]
DR   GeneID; 127933; -.
DR   KEGG; hsa:127933; -.
DR   MANE-Select; ENST00000489294.2; ENSP00000420270.1; NM_175866.5; NP_787062.1.
DR   UCSC; uc001gcc.3; human. [Q8TAS1-1]
DR   CTD; 127933; -.
DR   DisGeNET; 127933; -.
DR   GeneCards; UHMK1; -.
DR   HGNC; HGNC:19683; UHMK1.
DR   HPA; ENSG00000152332; Low tissue specificity.
DR   MIM; 608849; gene.
DR   neXtProt; NX_Q8TAS1; -.
DR   OpenTargets; ENSG00000152332; -.
DR   PharmGKB; PA134974001; -.
DR   VEuPathDB; HostDB:ENSG00000152332; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000157769; -.
DR   HOGENOM; CLU_693633_0_0_1; -.
DR   InParanoid; Q8TAS1; -.
DR   OMA; VMATFYP; -.
DR   OrthoDB; 1490376at2759; -.
DR   PhylomeDB; Q8TAS1; -.
DR   TreeFam; TF331856; -.
DR   PathwayCommons; Q8TAS1; -.
DR   Reactome; R-HSA-9634638; Estrogen-dependent nuclear events downstream of ESR-membrane signaling.
DR   SignaLink; Q8TAS1; -.
DR   SIGNOR; Q8TAS1; -.
DR   BioGRID-ORCS; 127933; 18 hits in 1115 CRISPR screens.
DR   ChiTaRS; UHMK1; human.
DR   GeneWiki; UHMK1; -.
DR   GenomeRNAi; 127933; -.
DR   Pharos; Q8TAS1; Tbio.
DR   PRO; PR:Q8TAS1; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8TAS1; protein.
DR   Bgee; ENSG00000152332; Expressed in kidney epithelium and 193 other tissues.
DR   Genevisible; Q8TAS1; HS.
DR   GO; GO:0030424; C:axon; ISS:BHF-UCL.
DR   GO; GO:0032839; C:dendrite cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0071598; C:neuronal ribonucleoprotein granule; ISS:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC-UCL.
DR   GO; GO:0005524; F:ATP binding; IC:HGNC-UCL.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC-UCL.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; ISS:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:1990935; F:splicing factor binding; IEA:Ensembl.
DR   GO; GO:0016740; F:transferase activity; IC:HGNC-UCL.
DR   GO; GO:0031175; P:neuron projection development; ISS:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:HGNC-UCL.
DR   GO; GO:0045948; P:positive regulation of translational initiation; ISS:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:HGNC-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:HGNC-UCL.
DR   GO; GO:0046825; P:regulation of protein export from nucleus; IDA:HGNC-UCL.
DR   CDD; cd12465; RRM_UHMK1; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034372; UHMK1.
DR   InterPro; IPR034371; UHMK1_RRM.
DR   PANTHER; PTHR46962; PTHR46962; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Kinase; Nucleotide-binding; Nucleus;
KW   Reference proteome; RNA-binding; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..419
FT                   /note="Serine/threonine-protein kinase Kist"
FT                   /id="PRO_0000086777"
FT   DOMAIN          23..304
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000305"
FT   DOMAIN          324..406
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176,
FT                   ECO:0000305"
FT   ACT_SITE        158
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         29..37
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         54
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         1..89
FT                   /note="MAGSGCAWGAEPPRFLEAFGRLWQVQSRLGSGSSASVYRVRCCGNPGSPPGA
FT                   LKQFLPPGTTGAAASAAEYGFRKERAALEQLQGHRNI -> MFLTRPKVCVDLNRR
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046145"
FT   VAR_SEQ         342..344
FT                   /note="DVV -> GLC (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_004908"
FT   VAR_SEQ         345..419
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_004909"
FT   VARIANT         159
FT                   /note="L -> V (in dbSNP:rs34466082)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041272"
FT   VARIANT         197
FT                   /note="Y -> D (in dbSNP:rs56201055)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041273"
FT   MUTAGEN         54
FT                   /note="K->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:12093740"
SQ   SEQUENCE   419 AA;  46546 MW;  903E982EE12A8CF8 CRC64;
     MAGSGCAWGA EPPRFLEAFG RLWQVQSRLG SGSSASVYRV RCCGNPGSPP GALKQFLPPG
     TTGAAASAAE YGFRKERAAL EQLQGHRNIV TLYGVFTIHF SPNVPSRCLL LELLDVSVSE
     LLLYSSHQGC SMWMIQHCAR DVLEALAFLH HEGYVHADLK PRNILWSAEN ECFKLIDFGL
     SFKEGNQDVK YIQTDGYRAP EAELQNCLAQ AGLQSDTECT SAVDLWSLGI ILLEMFSGMK
     LKHTVRSQEW KANSSAIIDH IFASKAVVNA AIPAYHLRDL IKSMLHDDPS RRIPAEMALC
     SPFFSIPFAP HIEDLVMLPT PVLRLLNVLD DDYLENEEEY EDVVEDVKEE CQKYGPVVSL
     LVPKENPGRG QVFVEYANAG DSKAAQKLLT GRMFDGKFVV ATFYPLSAYK RGYLYQTLL
//
